article thumbnail

The hospital pharmacy landscape in 2024

Hospital Pharmacy Europe

Tiene Bauters, PharmD PhD, Pharmacy Department , Ghent University Hospital in Belgium, offers her take on what’s hot on the horizon for hospital pharmacy in 2024. These will undoubtedly present great opportunities for hospital pharmacists and their teams.

Hospitals 111
article thumbnail

Include penicillin allergy history in medicines reconciliation to ensure accurate status, says RPS

Hospital Pharmacy Europe

Millions could be missing out on the most effective antibiotic choice because they mistakenly believe they are allergic to penicillin, prolonging their recovery, increasing the risk of infection and even leading to hospital admission. The researchers had estimated that incorrect penicillin allergy records affect 2.7

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

However, the American Medical Association (AMA) released a statement warning that while most patients benefit from Paxlovid, it is not for everyone. The US FDA has not announced any updates to Lagevrio’s label.

Labelling 111
article thumbnail

Sentinel Events Should Result In A Blameless Society — Not Make The Employee The Scapegoat

The Happy PharmD

Previously I wrote about medication errors in my hospital. This is an atmosphere in a hospital that blames the system rather than the person. Should a medication error occur, and the employee act properly, nothing would happen to the employee. A few of my hospitals had just culture atmospheres.

article thumbnail

Pharmacogenetics: What pharmacists need to know

Hospital Pharmacy Europe

If these results can be integrated into a patient’s medical records, they can be used to inform the prescription of future medicines throughout that patient’s life. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: An open-label, multicentre, controlled, cluster-randomised crossover implementation study.

Hospitals 111